Werkgroep Cardiologische centra Nederland English

AEGIS-II (Inclusie)

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Middel
CSL112
Populatie
ASCVD
Fase
III
Jaar aanvang
2017

Studiedirecteur

drs. B.J.B. Hamer (Cardioloog)
Amersfoort, Meander Medisch Centrum